|
69
|
250
|
5l5rA |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
67
|
250
|
5l65A |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
255
|
652
|
4z40A |
Active site complex bambc of benzoyl coenzyme a reductase as isolated |
|
56
|
195
|
5l5yJ |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
61
|
220
|
5leyH |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
68
|
242
|
5l5bD |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
|
68
|
242
|
5laiD |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
63
|
222
|
5lajL |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
76
|
248
|
5lf6B |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
59
|
195
|
5l5tJ |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
59
|
226
|
5l67H |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
59
|
226
|
5laiH |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
85
|
309
|
5a7jA |
Crystal structure of inpp5b in complex with benzene 1,2,4,5- tetrakisphosphate |
|
64
|
200
|
5lf0K |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
56
|
204
|
5l5aI |
Yeast 20s proteasome with human beta5i (1-138; r57t) |
|
67
|
240
|
5l5fC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
58
|
204
|
5l64I |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
62
|
231
|
5l62E |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
63
|
231
|
5l69E |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
71
|
240
|
5l5yC |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
61
|
195
|
5laiJ |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
64
|
233
|
5le5D |
Native human 20s proteasome at 1.8 angstrom |
|
61
|
233
|
5lf6D |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
58
|
195
|
5l5aJ |
Yeast 20s proteasome with human beta5i (1-138; r57t) |
|
64
|
241
|
5l5wG |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
63
|
222
|
5l67L |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
67
|
244
|
5lajB |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
66
|
250
|
5l66A |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
69
|
243
|
5lajF |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
62
|
233
|
5lf0D |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
62
|
195
|
5l54J |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
|
89
|
313
|
5a7iA |
Crystal structure of inpp5b in complex with biphenyl 3,3',4,4',5,5'- hexakisphosphate |
|
64
|
237
|
5lf6C |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
69
|
240
|
5l64C |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
59
|
226
|
5l6aH |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
67
|
242
|
5lajD |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
68
|
239
|
5lf3F |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
63
|
241
|
5l54G |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
|
64
|
241
|
5l61G |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14 |
|
62
|
241
|
5l64G |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
67
|
233
|
5l5qM |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
|
55
|
204
|
5lexI |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
60
|
195
|
5l5hJ |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
68
|
233
|
5l5wM |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
64
|
241
|
5lajG |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
69
|
222
|
5lcaA |
Vim-2 metallo-beta-lactamase in complex with 3-oxo-2-(3-(trifluoromethyl)phenyl)isoindoline-4-carboxylic acid (compound 17) |
|
59
|
195
|
5l5eJ |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
69
|
243
|
5l54F |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
|
71
|
244
|
5l5rB |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
62
|
220
|
5lf6H |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
